This medical device firm supplies hospitals worldwide with single-use products for critical care, surgery, and interventional procedures.

The recent Teleflex update centers on a refreshed fair value estimate, which has shifted from about US$124.14 to about US$129.25 as analysts tweak their models for revenue growth and the discount rate ...

The latest announcement is out from Teleflex ( (TFX) ).

Teleflex TFX posted solid fourth-quarter performance, ending the year on a stable note. On one hand, currency was a major headwind across all segments this fiscal year, and supply chain and staffing ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

Ratings for Teleflex (NYSE:TFX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

WAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2024 Global Impact Report. The ...

Shares of Teleflex Inc. TFX slid 2.25% to $104.54 Thursday, on what proved to be an all-around poor trading session for the ...

Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...

Look here for a clue. There's no foolproof way to know the future for Teleflex (NYSE: TFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- and ...